<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00479661</url>
  </required_header>
  <id_info>
    <org_study_id>3005012</org_study_id>
    <secondary_id>EudraCT 2006-006030-17</secondary_id>
    <nct_id>NCT00479661</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine Versus Propofol for Continuous Sedation in the Intensive Care Unit (ICU)</brief_title>
  <acronym>Prodex</acronym>
  <official_title>A Prospective, Multi-centre, Randomised, Double-blind Comparison of Intravenous Dexmedetomidine With Propofol for Continuous Sedation of Ventilated Patients in Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Orion Corporation, Orion Pharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Orion Corporation, Orion Pharma</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients in the ICU who need help with their breathing are put onto a machine called a
      ventilator and are also given a medicine, called a sedative, which helps them to sleep and
      makes them more comfortable. Propofol is a sedative that is routinely used for these
      purposes.

      For most patients the aim of sedation is to make them sleepy but still able to respond to
      nursing staff (light sedation).

      Dexmedetomidine is a new sedative for use in intensive care and in this clinical
      study,dexmedetomidine is compared to propofol. It is thought that dexmedetomidine might be
      slightly better at allowing patients to be sleepy but still respond to people around them. It
      also does not appear to affect patient's breathing. The purpose of this study is to test
      whether dexmedetomidine really does have these advantages compared to propofol.

      In this study, we hope to show that: dexmedetomidine is at least as good as propofol in
      helping patients to sleep better and making them more comfortable, and that they are able to
      communicate and cooperate better with the staff treating them, and that patients treated with
      dexmedetomidine require a shorter time on the ventilator than those treated with propofol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a phase III, multi-centre, prospective, randomised, double-blind, double-dummy,
      active comparator study. The study consists of three periods: screening, double-dummy
      treatment and follow-up period.

      All patients admitted to ICU will be pre-screened according to inclusion and exclusion
      criteria prior to informed consent using available clinical data.

      Informed consent, screening and randomisation procedures should be completed within 72 hours
      from the time of admission to ICU and within 48 hours from starting continuous sedation.
      Eligible study subjects requiring light to moderate sedation (Richmond Agitation-Sedation
      Scale [RASS] = 0 to -3) will be randomised to either continue on propofol or switch to
      dexmedetomidine. Patients should not have received any other continuously or regularly
      administered sedative agent than propofol during the last 12 hours except for opioid
      analgesics. Study treatments will be titrated to achieve an individually targeted sedation
      range determined on a daily basis. Rescue treatment (i.e. midazolam boli) may be given if
      needed to achieve the target depth of sedation. Continued need for sedation will be assessed
      at a daily sedation stop, conducted at the same time each day. First sedation stop may be
      12-36 hours from randomisation, depending on the time of day the study subject is randomised.
      The duration of study treatment is limited to a maximum of 14 days from randomisation.
      Following withdrawal of sedation, study subjects will be monitored for 48 hours and contacted
      by telephone 31 and 45 days after randomisation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Depth of sedation using the RASS. The target RASS range (target depth of sedation) should be 0 to -3 for a patient to be included in the study. The target may be amended during the study treatment, if clinically required.</measure>
    <time_frame>2 hourly and before each rescue treatment dose during the treatment period and the 48-hour follow-up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>Start and stop times of mechanical ventilation while the patient is treated in the ICU</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nurse's assessment of subject communication with visual analogue scales (VAS)</measure>
    <time_frame>At the end of each nursing shift during study treatment and 48 h follow-up period in the ICU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>Admission and discharge dates and times during the current ICU treatment period</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">500</enrollment>
  <condition>Continuous Sedation in Initially Sedated Adults in ICU</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexmedetomidine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Propofol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Continuous infusion</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Continuous infusion</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age more than 18 years

          -  Clinical need for sedation of an initially intubated (or tracheotomised) and
             ventilated (with inspiratory assistance) patient

          -  Prescribed light to moderate sedation (target RASS = 0 to -3) using propofol

          -  Patients should be randomised within 72 hours from ICU admission and within 48 hours
             of commencing continuous sedation in the ICU

          -  Patients should have an expected requirement for sedation more than 24 hours from time
             of randomisation

          -  Written informed consent must be obtained according to local regulations before
             starting any study procedures other than pre-screening

        Exclusion Criteria:

          -  Acute severe intracranial or spinal neurological disorder due to vascular causes,
             infection, intracranial expansion or injury

          -  Uncompensated acute circulatory failure at time of randomisation (severe hypotension
             with mean arterial pressure [MAP] &lt; 55 mmHg despite volume and pressors)

          -  Severe bradycardia (heart rate [HR] &lt; 50 beats/min)

          -  AV-conduction block II-III (unless pacemaker installed)

          -  Severe hepatic impairment (bilirubin &gt; 101 µmol/l)

          -  Need for muscle relaxation at the time of randomisation (may only be used for
             intubation and initial stabilization)

          -  Loss of hearing or vision, or any other condition which would significantly interfere
             with the collection of study data

          -  Burn injuries requiring regular anaesthesia or surgery

          -  Use of centrally acting α2 agonists or antagonists at the time of randomisation,
             notably clonidine

          -  Patients who have or are expected to have treatment withdrawn or withheld due to poor
             prognosis

          -  Patients receiving sedation for therapeutic indications rather than to tolerate the
             ventilator (e.g. epilepsy)

          -  Patients who are unlikely to require continuous sedation during mechanical ventilation
             (e.g. Guillain-Barré syndrome)

          -  Patients who are unlikely to be weaned from mechanical ventilation e.g.
             diseases/injuries primarily affecting the neuromuscular function of the respiratory
             apparatus such as clearly irreversible disease requiring prolonged ventilatory support
             (e.g. high spinal cord injury or advanced amyotrophic lateral sclerosis)

          -  Distal paraplegia

          -  Positive pregnancy test or currently lactating

          -  Received any investigational drug within the preceding 30 days

          -  Concurrent participation in any other interventional study (any study in which
             patients are allocated to different treatment groups and/or non-routine diagnostic or
             monitoring procedures are performed)

          -  Previous participation in this study

          -  Any other condition which, in the investigator's opinion, would make it detrimental
             for the subject to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Esko Ruokonen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kuopio University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kati Kaijasilta, MSc (Pharm)</last_name>
    <role>Study Director</role>
    <affiliation>Orion Corporation, Orion Pharma</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Onze-Lieve-Vrouw Ziekenhuis, Anesthesia and Intensive Care Dept. Moorselbaan 164</name>
      <address>
        <city>Aalst</city>
        <zip>9300</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ziekenhuis Oost-Limburg Location Sint-Jan, Dept.of Anesthesiology, Schiepse Bos</name>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HUCH, Jorvi Hospital, Turuntie 150,</name>
      <address>
        <city>Espoo</city>
        <zip>02740</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HUCH, Meilahti Hospital, Haartmaninkatu 4, P.O.Box 340,</name>
      <address>
        <city>Helsinki</city>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Carelia Central Hospital, Tikkamaentie 16,</name>
      <address>
        <city>Joensuu</city>
        <zip>80210</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <zip>70210</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paijat-Hame Central Hospital, Keskussairaalankatu 7,</name>
      <address>
        <city>Lahti</city>
        <zip>15850</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Carelia Central Hospital, Valto Kakelan katu 1,</name>
      <address>
        <city>Lappeenranta</city>
        <zip>53130</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seinajoki Central Hospital, Hanneksenrinne 7,</name>
      <address>
        <city>Seinajoki</city>
        <zip>60220</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital, ICU, Teiskonntie 35, P.O.Box 2000,</name>
      <address>
        <city>Tampere</city>
        <zip>33521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charite Berlin Klinik fur Anasthesiologie und Operative Intensivmedizin (CCM), Luisenstrasse 65 (LU 65),</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Bonn, Klinik u. Poliklinik f. Anasthesiologie u.</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum, Krankenhausstrsse 12,</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Johann-Wolfgang-Goethe Universitat, Klinik fur Anasthesiologie,</name>
      <address>
        <city>Frankfurt am Main</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ. Giessen und Marburg Abt. Anaesthesiologie, Intensivmedizin, Schmerztherapie &amp; Palliativmedizin, Rudolf-Buchheim-Strasse 7,</name>
      <address>
        <city>Giessen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Halle, Universitatsklinik fur Anasthelsiologie und Operative Intensivmedizin, Ernst-Grube Strasse 40</name>
      <address>
        <city>Halle</city>
        <zip>06097</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Heidelberg Klinik fur Anasthesiologie, Im Neuenheimer Feld 110,</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik fur Anasthesiologie, Intensivmedizin und Schmerztherapie, Universitatsklinikum des Saarlandes, Gebaude 57,</name>
      <address>
        <city>Homburg</city>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Leipzig, Klinik und Poliklinik fur Anaesthesiologie und Intensivtherapie, Liebigstrasse 29</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum St. Georg, Delitzscher Strasse 141, Hause 20, 1. Etage, Zimmer 204</name>
      <address>
        <city>Leipzig</city>
        <zip>04129</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Tubingen, Klinik fur Anasthesiologie und Intensivmedizin</name>
      <address>
        <city>Tubingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum-Wetzlar-Braunfels, Forsthaus Strasse 1-3a</name>
      <address>
        <city>Wetzlar</city>
        <zip>35578</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jeroen Bosch Ziekenhuis, Postbus 90153,</name>
      <address>
        <city>Hertogenbosch</city>
        <zip>5200 ME</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westfries Gasthuis, Department Intensieve Zorgen, Maelsonstraat 3,</name>
      <address>
        <city>Hoorn</city>
        <zip>1624 NP</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rivierenland Hospital, Pres. Kennedylaan 1,</name>
      <address>
        <city>Tiel</city>
        <zip>4001 WP</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kemerovo Stte Medical Academy, 22/A Voroshilov Street</name>
      <address>
        <city>Kemerovo</city>
        <zip>650026</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Municipal Hospital #2, Krasnodar Diversified Treatment and Diagnostic Association, 6, Ulica Krasnykh Partizan Building 2,</name>
      <address>
        <city>Krasnodar</city>
        <zip>350012</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Federal State Institution Russian Centre of Functional Surgical Gastroenterology, Krasnodor Municipal Hospital, 4, ulica Sedina,</name>
      <address>
        <city>Krasnodar</city>
        <zip>350086</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Institution B.B. Petrovsky Russian Research Centre of Surgery of RAMS, 2, Abrikosovsky per.</name>
      <address>
        <city>Moscow</city>
        <zip>119992</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State Healthcare Institution V.A. Baranov Republican Hospital, 3, Pirogova Ulica,</name>
      <address>
        <city>Petrozavodsk</city>
        <zip>185019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Federal State Healthcare Institution L.G. Sokolov Clinical Hospital, #122 of FMBA of Russia, 4, pr-t Kultury</name>
      <address>
        <city>St .Petersburg</city>
        <zip>194291</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Academy of Postgraduate Study, 41, ulica Kirochnaya,</name>
      <address>
        <city>St. Petersburg</city>
        <zip>191015</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inselspital, Freiburgstsrasse 4,</name>
      <address>
        <city>Bern</city>
        <zip>CH-3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Suffolk Hospital NHS Trust, Hardwick Lane, Suffolk,</name>
      <address>
        <city>Bury Saint Edmunds</city>
        <zip>IP33 2QZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Edinburgh University, Little France Crescent, Edinburgh Royal Infirmary,</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 2SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leeds General Infirmary, Great George Street</name>
      <address>
        <city>Leeds</city>
        <zip>LS1 3EX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint John's Hospital, Howden Road West,</name>
      <address>
        <city>Livingston</city>
        <zip>EH54 6PP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Thomas Hospital, Lambeth Palace Road,</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint George's Hospital, Blackshaw Road, Tooting</name>
      <address>
        <city>London</city>
        <zip>SW17 0QT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Freeman Hospital, Freeman Road High Heaton,Newcastle Upon Tyne</name>
      <address>
        <city>Tyne and Wear</city>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Finland</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Russian Federation</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2007</study_first_submitted>
  <study_first_submitted_qc>May 25, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2007</study_first_posted>
  <last_update_submitted>August 12, 2010</last_update_submitted>
  <last_update_submitted_qc>August 12, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2010</last_update_posted>
  <responsible_party>
    <name_title>Kati Kaijasilta</name_title>
    <organization>Orion corporation, Orion Pharma, Clinical R&amp;D</organization>
  </responsible_party>
  <keyword>initial sedation</keyword>
  <keyword>mechanical ventilation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

